Neoadjuvant Chemotherapy Followed by Radiation Therapy and Gemcitabine/Sorafenib/Vorinostat in Pancreatic Cancer

NCT02349867 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma
Stage IA Pancreatic Cancer
Stage IB Pancreatic Cancer
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer
Stage III Pancreatic Cancer
Recurrent Pancreatic Carcinoma

Interventions

DRUG: Gemcitabine
DRUG: Sorafenib
DRUG: Vorinostat
RADIATION: 3-Dimensional Conformal Radiation Therapy
RADIATION: Intensity-Modulated Radiation Therapy
OTHER: RosetteSep
OTHER: DEPfff

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]